Role in tumorigenesis of silent mutations in the TP53 gene.
Over 10,000 mutations in the TP53 suppressor gene have been recorded in the International Agency for Research on Cancer (IARC) tumor data base. About 4% of these mutations are silent. It is a question whether these mutations play a role in tumor development. In order to approach this question, we asked whether the reported silent mutations are randomly distributed throughout the TP53 gene. The p53 data base was searched exon by exon. From the frequency of codons with no silent mutations, the average number of silent mutations per codon for each exon was calculated using the Poisson distribution. The results indicate the distribution to be non-random. About one-third of all silent mutations occur in "hot-spots" and after subtraction of these hot-spots, the remaining silent mutations are randomly distributed. In addition, the percentage of silent mutations among the total in the silent mutation hot-spots is close to that expected for random mutation. We conclude that most of the silent mutations recorded in tumors play no role in tumor development and that the percentage of silent mutation is an indication of the amount of random mutation during tumorigenesis. Silent mutations occur to a significantly different extent in different tumor types. Tumors of the esophagus and colon have a low frequency of silent mutations, tumors of the prostate have a high frequency.
Strauss
B S
BS
Department of Molecular Genetics and Cell Biology, The University of Chicago, 920 East 58th Street, 60637, Chicago, IL, USA. bs19@midway.uchicago.edu
D003062:Codon / Q000235:genetics; D016208:Databases, Factual; D005260:Female; D016158:Genes, p53; D006801:Humans; D008297:Male; D009154:Mutation; D009369:Neoplasms / Q000209:etiology* / Q000235:genetics*
D003062:Codon